Presentation Information
[28ISP-26]Development of liposome cancer drug FF-10832 (PEGylated Gemcitabine liposome) and FF-10850 (PEGylated Toptecan liposome), application of the CMC technologies for liposome CDMO services
○Mikinaga Mori1, Shiro Sonoke1, Kohei Ono1 (1. FUJIFILM Corporation)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.